Quiz
Article
NeurologyLive® Brain Games: June 8, 2025
Author(s):
Key Takeaways
- NeurologyLive Brain Games offers weekly quizzes on diverse neurology topics, including dementia, epilepsy, and stroke, with a focus on specific themes like parasomnias.
- Each quiz consists of three questions crafted by experts in neurological care and advocacy, providing a challenging experience for participants.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on the care of parasomnias.
Welcome to NeurologyLive® Brain Games! This weekly quiz series, which goes live every Sunday morning, will feature questions on a variety of clinical and historical neurology topics, written by physicians, clinicians, and experts in the fields of neurological care and advocacy.
Test your mettle each week with 3 questions that cover a variety of aspects in the field of neurology, with a focus on dementia and Alzheimer disease, epilepsy and seizure disorders, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, sleep disorders, and stroke and cerebrovascular disease.
This week's questions include the theme of parasomnias.
Click here to check out the prior iterations of Brain Games.
Interested in submitting quiz questions? Contact our editor, Marco Meglio, via email: mmeglio@neurologylive.com.
Which of the following is considered first-line pharmacologic treatment for REM sleep behavior disorder (RBD)?
Which behavioral intervention is recommended to reduce risk in patients with confusional arousals and sleepwalking?
What class of medications is most often used off-label to treat severe cases of non-REM parasomnias in adults?
How did you do on this week's quiz? Let us know with a response to the poll below. Don't forget to share and compare your results with your friends!
How many questions did you get correct?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
